CORDEN PHARMA CHENOVE
CORDEN PHARMA CHENOVE (France) holds 7 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 6 active ingredients, holds 3 active Type IV (excipient) Drug Master Files and is linked to 1 FDA-registered manufacturing site. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CORDEN PHARMA CHENOVE: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/corden-pharma-chenove
Overview
CORDEN PHARMA CHENOVE is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering BISOPROLOL FUMARATE; CHOLINE FENOFIBRATE DRUG SUBSTANCE; FENOFIBRATE; FENOFIBRATE INTERMEDIATE DRUG SUBSTANCE; NEBIVOLOL HYDROCHLORIDE; OXYBUTYNIN HYDROCHLORIDE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which CORDEN PHARMA CHENOVE holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
CORDEN PHARMA CHENOVE holds 7 active (7 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- NEBIVOLOL HYDROCHLORIDEActive2015-12-03
- CHOLINE FENOFIBRATE DRUG SUBSTANCEActive2007-10-15
- FENOFIBRATE INTERMEDIATE DRUG SUBSTANCEActive2007-07-24
- TETRABENAZINEActive2003-07-03
- BISOPROLOL FUMARATEActive1998-12-22
- OXYBUTYNIN HYDROCHLORIDEActive1997-01-09
- FENOFIBRATEActive1996-08-05
Excipient Drug Master Files
CORDEN PHARMA CHENOVE holds 3 active (3 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOCHOLINE (DPPC)Active2024-06-11
- 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE (DSPC)Active2024-06-11
- SODIUM STEARYL FUMARATEActive2012-04-20
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to CORDEN PHARMA CHENOVE, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2009-05-06
FDA Warning Letter (drug product)
Is this CORDEN PHARMA CHENOVE?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.